Barrett's metaplasia

The rate of oesophageal adenocarcinoma is increasing in the western world and has a poor prognosis mainly because individuals present at a late stage. Attempts to intervene at an early stage of tumour progression have not proven cost effective, although lesions identified during surveillance programmes have a better prognosis. As a consequence, there has been renewed interest in strategies that might prevent the precursor lesion Barrett's oesophagus. Furthermore, there is an improved understanding of genetic and environmental interactions necessary for the clonal expansion and propagation of metaplastic premalignant lesions. Clearly, three mechanisms promote cancer progression--inheritance of germ-line mutations or polymorphisms, sporadic mutagenesis, and local epigenetic alterations. Locally produced cytokines and bile acids in the refluxate create a microenvironment that sets the scene for metaplastic transformation of the oesophageal epithelium, mainly by directly affecting metaplastic stem cells.

[1]  D J Ballard,et al.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.

[2]  R. Cherian,et al.  Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma , 2000, American Journal of Gastroenterology.

[3]  M. Dixon Patterns of inflammation linked to ulcer disease. , 2000, Bailliere's best practice & research. Clinical gastroenterology.

[4]  H. Shinzawa,et al.  Endoscopic observation of squamous metaplasia of the stomach: a report of two cases. , 2000, Endoscopy.

[5]  H. Friess,et al.  Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis , 2000, Gut.

[6]  H. Barr,et al.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.

[7]  R. Poulsom,et al.  Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[8]  B. Dahms,et al.  Barrett's esophagus in three children after antileukemia chemotherapy , 1987, Cancer.

[9]  M. Omary,et al.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. , 2000, Gastroenterology.

[10]  D. Schaid,et al.  Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. , 1997, Gastroenterology.

[11]  T. Marteau,et al.  What parents are told after prenatal diagnosis of a sex chromosome abnormality: interview and questionnaire study , 2001, BMJ : British Medical Journal.

[12]  R. Horvat,et al.  Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori. , 1997, The American journal of gastroenterology.

[13]  R. Grosschedl,et al.  Regulation of LEF-1/TCF transcription factors by Wnt and other signals. , 1999, Current opinion in cell biology.

[14]  G. Tytgat,et al.  Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. , 2000 .

[15]  J. Jankowski,et al.  Barrett's mucosa: remodelling by the microenvironment , 2000, The Journal of pathology.

[16]  Á. Lanas,et al.  Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. , 1997, Gut.

[17]  Jesper Lagergren,et al.  Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma , 2000, Annals of Internal Medicine.

[18]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[19]  D. Hopwood,et al.  Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. , 1993, The American journal of gastroenterology.

[20]  J. Mecklin,et al.  Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis , 1999, Gut.

[21]  S. Spechler The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. , 1999, Gastroenterology.

[22]  M. Czaja,et al.  Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[23]  R. Sampliner,et al.  Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. , 1996, Cancer research.

[24]  N. Shepherd,et al.  The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. , 1998, The American journal of surgical pathology.

[25]  W. Hop,et al.  Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus , 1993, Cancer.

[26]  R. Donnelly,et al.  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. , 1993, Gut.

[27]  E. D. Williams,et al.  The demonstration of tissue clonality by X‐linked enzyme histochemistry , 1988, The Journal of pathology.

[28]  A. Younes,et al.  Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. , 1999, Human pathology.

[29]  J. Lagergren,et al.  Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.

[30]  R. Sampliner,et al.  Barrett's esophagus: update on screening, surveillance, and treatment. , 1999, Archives of internal medicine.

[31]  R. Sampliner,et al.  GERD, DGER, or both in Barrett's esophagus? , 1997, The American journal of gastroenterology.

[32]  G. Triadafilopoulos Proton pump inhibitors for Barrett's oesophagus , 2000, Gut.

[33]  K. Okita,et al.  Metaplastic polyp of the colon develops in response to inflammation , 1999, Journal of gastroenterology and hepatology.

[34]  D. Polk,et al.  Conversion of TNFα from Antiproliferative to Proliferative Ligand in Mouse Intestinal Epithelial Cells by Regulating Mitogen-Activated Protein Kinase , 1999 .

[35]  R. O'Moore,et al.  Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus , 1988, The British journal of surgery.

[36]  R. Stenling,et al.  The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia. , 2000, Scandinavian journal of gastroenterology.

[37]  J. Sung,et al.  Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. , 2000, Gastroenterology.

[38]  C. McConkey,et al.  The rising trend in oesophageal adenocarcinoma and gastric cardia. , 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  N. Wright,et al.  Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets , 1999, The Journal of pathology.

[40]  D. Evans,et al.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.

[41]  Carissa A. Sanchez,et al.  Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. , 2000, Journal of the National Cancer Institute.

[42]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[43]  M. Kaminishi,et al.  Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism , 1998, Gut.

[44]  A. Cameron,et al.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium. , 1992, Gastroenterology.

[45]  P. Kuppen,et al.  Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors1 , 2000, The Journal of Immunology.

[46]  J. Richter,et al.  Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. , 1994, Gastroenterology.

[47]  D. Wakelin,et al.  Role of T helper 2 cells in intestinal goblet cell hyperplasia in mice infected with Trichinella spiralis. , 1997, Gastroenterology.

[48]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[49]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[50]  K. Dabbagh,et al.  Agarose plug instillation causes goblet cell metaplasia by activating EGF receptors in rat airways. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[51]  A. Poynton,et al.  Carcinoma arising in familial Barrett's esophagus. , 1996, The American journal of gastroenterology.

[52]  J. Jankowski,et al.  Gastro-oesophageal cancer: death at the junction , 2000, BMJ : British Medical Journal.

[53]  C. Potten,et al.  Gut instincts: thoughts on intestinal epithelial stem cells. , 2000, The Journal of clinical investigation.

[54]  G. Kollias,et al.  Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis , 1999, Nature Medicine.

[55]  Vujanić,et al.  Diversion colitis in children: an iatrogenic appendix vermiformis? , 2000, Histopathology.

[56]  R. Fass,et al.  Extension of squamous epithelium into the proximal stomach: a newly recognized mucosal abnormality. , 2000, Endoscopy.

[57]  C. Price,et al.  Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. , 1995, Human molecular genetics.

[58]  J. Goldblum,et al.  Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. , 1998, Gastroenterology.

[59]  B. Vogelstein,et al.  Clonal origin of bladder cancer. , 1992, The New England journal of medicine.

[60]  P. Sodhani,et al.  Columnar and metaplastic cells in vault smears: cytologic and colposcopic study , 1999, Cytopathology : official journal of the British Society for Clinical Cytology.

[61]  J. Cameron,et al.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. , 1985, American journal of surgery.

[62]  Ian Tomlinson,et al.  Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.

[63]  R. Fitzgerald,et al.  Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.

[64]  D. Skinner,et al.  Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.